Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Progress in Growth Factor Research|January 1, 1992
Clinical applications of interleukin-2A von Rohr, N Thatcher
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II study with mitomycin, ifosfamide and carboplatin in inoperable non-small cell lung cancerA von Rohr, H Anderson, R McIntosh, et al.
Schweizerische Medizinische Wochenschrift|January 11, 1994
[Prognostic value of bone marrow examinations on day 8 and day 17 of the first induction therapy cycle in acute myeloid leukemia]K Zingg, A von Rohr, M F Fey, et al.
Schweizerische Medizinische Wochenschrift|September 7, 1991
[Syndrome of inappropriate ADH secretion (SIADH) in small-cell bronchus carcinoma]A von Rohr, T Cerny, R A Joss, et al.
British Journal of Cancer|January 1, 1993
Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancyA von Rohr, A K Ghosh, N Thatcher, et al.
Oncology|March 5, 2011
Bortezomib retreatment in relapsed multiple myeloma - results from a retrospective multicentre survey in Germany and SwitzerlandI Hrusovsky, B Emmerich, A von Rohr, et al.
Schweizerische Medizinische Wochenschrift|November 24, 1998
[2-CDA in treatment of hairy cell leukemia: a comparison between intravenous and subcutaneous administration. Swiss Study Group of Applied Cancer Research]R A Sperb, A von Rohr, D Ratschiller, et al.
Blood|February 15, 1994
Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probeM F Fey, S Liechti-Gallati, A von Rohr, et al.
Bone Marrow Transplantation|January 1, 1995
The number of circulating CD34+ blood cells predicts the colony-forming capacity of leukapheresis products in childrenK Leibundgut, A von Rohr, K Brülhart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemiasD C Betticher, M F Fey, A von Rohr, et al.
Pageof 2